The expression of miR-181a decreases in neural progenitor cells in the subventricular zone after stroke (Liu et al., 2017), a time of increased neurogenesis, further suggesting that miR-181a impedes neuronal differentiation, a hypothesis supported by our observations of increased MAP2 expression in stem cells treated with miR-181a inhibitor (Fig. 6). Here, MAP2 is linked to stroke disorder.